BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8719743)

  • 21. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle.
    Philpot J; Sewry C; Pennock J; Dubowitz V
    Neuromuscul Disord; 1995 Jul; 5(4):301-5. PubMed ID: 7580243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large series of immunohistochemically confirmed cases of congenital muscular dystrophy seen over a period of one decade.
    Nagappa M; Atchayaram N; Narayanappa G
    Neurol India; 2013; 61(5):481-7. PubMed ID: 24262449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle.
    Trevisan CP; Martinello F; Ferruzza E; Fanin M; Chevallay M; Tomé FM
    Childs Nerv Syst; 1996 Oct; 12(10):604-10. PubMed ID: 8934020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy.
    Pegoraro E; Mancias P; Swerdlow SH; Raikow RB; Garcia C; Marks H; Crawford T; Carver V; Di Cianno B; Hoffman EP
    Ann Neurol; 1996 Nov; 40(5):782-91. PubMed ID: 8957020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual function in children with merosin-deficient and merosin-positive congenital muscular dystrophy.
    Mercuri E; Anker S; Philpot J; Sewry C; Dubowitz V; Muntoni F
    Pediatr Neurol; 1998 May; 18(5):399-401. PubMed ID: 9650678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of congenital muscular dystrophy and clinical significance of merosin expression].
    Xiong H; Yao S; Yuan Y; Chang XZ; Wu Y; Bao XH; Zhang YH; Wu HS; Chen L; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):918-23. PubMed ID: 17254461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Congenital muscular dystrophy: report on 10 cases].
    Olivé M; Roig M; Bonaventura I; Navarro C
    Neurologia; 1994 Nov; 9(9):387-92. PubMed ID: 7811489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency.
    Villanova M; Malandrini A; Toti P; Salvestroni R; Six J; Martin JJ; Guazzi GC
    J Submicrosc Cytol Pathol; 1996 Jan; 28(1):1-4. PubMed ID: 8929621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging of pelvic and thigh muscles in congenital muscular dystrophy.
    Oto A; Aydingöz U; Başgün N; Talim B; Karaağaoğlu E; Topaloğlu H
    Turk J Pediatr; 2001; 43(1):44-51. PubMed ID: 11297158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital muscular dystrophy with partial merosin deficiency and late onset epilepsy.
    Martinello F; Angelini C; Trevisan CP
    Eur Neurol; 1998 Jul; 40(1):37-45. PubMed ID: 9693231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy.
    Shorer Z; Philpot J; Muntoni F; Sewry C; Dubowitz V
    J Child Neurol; 1995 Nov; 10(6):472-5. PubMed ID: 8576559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status.
    Mercuri E; Muntoni F; Berardinelli A; Pennock J; Sewry C; Philpot J; Dubowitz V
    Neuropediatrics; 1995 Feb; 26(1):3-7. PubMed ID: 7791947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging.
    Philpot J; Cowan F; Pennock J; Sewry C; Dubowitz V; Bydder G; Muntoni F
    Neuromuscul Disord; 1999 Mar; 9(2):81-5. PubMed ID: 10220862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Merosin-negative congenital muscular dystrophy: diffusion-weighted imaging findings of brain.
    Alkan A; Sigirci A; Kutlu R; Aslan M; Doganay S; Yakinci C
    J Child Neurol; 2007 May; 22(5):655-9. PubMed ID: 17690079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical evaluation of merosin deficiency in congenital muscular dystrophies.
    Brett FM; Loring P; Caesar A; Burke M; Brennan RP; King M; Farrell MA
    Arch Pathol Lab Med; 1998 Jan; 122(1):69-71. PubMed ID: 9448020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities.
    Sunada Y; Edgar TS; Lotz BP; Rust RS; Campbell KP
    Neurology; 1995 Nov; 45(11):2084-9. PubMed ID: 7501163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital muscular dystrophy.
    Huang FL; Mak SC; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):165-9. PubMed ID: 10677931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin.
    Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K
    Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential neuroradiological and neurophysiological studies in a Japanese girl with merosin-deficient congenital muscular dystrophy.
    Fujii Y; Sugiura C; Fukuda C; Maegaki Y; Ohno K
    Brain Dev; 2011 Feb; 33(2):140-4. PubMed ID: 20303224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minor neurological and perceptuo-motor deficits in children with congenital muscular dystrophy: correlation with brain MRI changes.
    Mercuri E; Dubowitz L; Berardinelli A; Pennock J; Jongmans M; Henderson S; Muntoni F; Sewry C; Philpot J; Dubowitz V
    Neuropediatrics; 1995 Jun; 26(3):156-62. PubMed ID: 7477754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.